BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 27312830)

  • 1. [Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease].
    Shim YK; Kim N
    Korean J Gastroenterol; 2016 Jun; 67(6):300-12. PubMed ID: 27312830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
    Iwamoto J; Saito Y; Honda A; Matsuzaki Y
    World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
    Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
    J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines of prevention and treatment for NSAID-related peptic ulcers].
    Lee JH; Lee YC; Jeon SW; Kim JW; Lee SW; ;
    Korean J Gastroenterol; 2009 Nov; 54(5):309-17. PubMed ID: 19934612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of peptic ulcer disease in the elderly.
    Pilotto A; Franceschi M; Maggi S; Addante F; Sancarlo D
    Drugs Aging; 2010 Jul; 27(7):545-58. PubMed ID: 20583849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of aspirin--and NSAID-induced peptic ulcers].
    Satoh K; Tanabe H; Ichiishi E; Ando K
    Nihon Rinsho; 2015 Jul; 73(7):1110-5. PubMed ID: 26165066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori].
    Schneider AR; Armbruster S; Mann J; von Römer W; Schuster T; Schepp W
    Z Gastroenterol; 2012 Nov; 50(11):1156-60. PubMed ID: 23150107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications.
    Lanas A
    Postgrad Med; 2005 Jun; 117(6):23-8, 31. PubMed ID: 16001765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.
    Zullo A; Hassan C; Campo SM; Morini S
    Drugs Aging; 2007; 24(10):815-28. PubMed ID: 17896831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal antiinflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: a trip from peptic ulcer to colon cancer.
    Lanas A
    Am J Med Sci; 2009 Aug; 338(2):96-106. PubMed ID: 19680014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
    Hunt RH; Bazzoli F
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
    Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
    World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.
    Hermansson M; Ekedahl A; Ranstam J; Zilling T
    BMC Gastroenterol; 2009 Apr; 9():25. PubMed ID: 19379513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.